SCHEMBL6282537

SCHEMBL6282537

C=CCCSSS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7591242 0.81 ALDH1A1 (0.41)
SCHEMBL7591246 0.75
SCHEMBL8352486 0.75 ALDH1A1 (0.40)
SCHEMBL8345558 0.73 ALDH1A1 (0.38)
SCHEMBL18196053 0.71
SCHEMBL7048417 0.69
SCHEMBL544944 0.67
SCHEMBL1016660 0.65
SCHEMBL6239330 0.63
SCHEMBL9887847 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112063363-A Environment-friendly glass cement and preparation method thereof 曹加月 2020-12-11 CN claimed
CN-113544266-A CRISPR-associated transposase systems and methods of use thereof 博德研究所 2021-10-22 CN disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
CN-112063363-A Environment-friendly glass cement and preparation method thereof 曹加月 2020-12-11 CN disclosed
US-20200221753-A1 TEXTURED INGESTIBLE PRODUCTS EETBE INC (US) 2020-07-16 US disclosed
US-20170196253-A1 TEXTURED INGESTIBLE PRODUCTS EETBE, INC. 2017-07-13 US disclosed
EP-3163998-A1 TEXTURED INGESTIBLE PRODUCTS Eetbe, Inc. (US) 2017-05-10 EP disclosed
WO-2016004057-A1 TEXTURED INGESTIBLE PRODUCTS EETBE, INC. (US) 2016-01-07 WO disclosed
US-20150125580-A1 METHODS, APPARATUS, AND PROCESS FOR THE MAKING OF EDIBLE PRODUCTS USING IRREVERSIBLE ELECTROPORATION AND/OR ELECTROLYSIS QVYJT FERNANDO (US) 2015-05-07 US disclosed
WO-2013072465-A1 DUAL GENE EXPRESSION SIGNATURE TO PREDICT CLINICAL OUTCOME AND THERAPEUTIC RESPONSE OF A PATIENT AFFECTED WITH A CANCER INSTITUT CURIE (FR) 2013-05-23 WO disclosed
JP-2005261397-A ACRYLAMIDE PRODUCTION INHIBITOR SANEI GEN FFI INC 2005-09-29 JP disclosed